Skip to main content
GutCited

Bacillus coagulans para Irritable Bowel Syndrome (IBS)

B

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbacillus\u002Dcoagulans\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusão

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

Key Study Findings

Meta-Analysis
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Dose: None vs: placebo Outcome: improvement in key IBS symptoms Efeito: None None

População: patients with IBS from 32 RCTs evaluating 10 probiotic strains

Randomized Controlled Trial n=61 4 weeks Double-blind
Effects of a Bacillus subtilis HU58 and Heyndrickxia faecalis SC208 spore-forming probiotic formula on gastrointestinal …
Dose: None vs: Placebo Outcome: Abdominal pain (NRS) and stool consistency (BSFS) Efeito: None P = 0.003 (pain); P = 0.035 (s

População: Adults with diarrhoea-predominant IBS (IBS-D)

Randomized Controlled Trial n=100 12 weeks
Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, …
Dose: None vs: Control Outcome: Pain outcomes Efeito: None P < .001

População: IBS patients

Meta-Analysis
Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review …
Dose: Various probiotic strains/mixtures vs: Placebo Outcome: Outcome-specific efficacy ranking in IBS Efeito: None None

População: Adults with IBS (RCTs)

Randomized Controlled Trial 12 weeks Double-blind
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in …
Dose: 20.5% vs: placebo Outcome: IBS symptom improvement Efeito: None p = 0.038

População: Adults with IBS

Review
Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives.
Dose: None vs: None Outcome: colitis/IBD severity Efeito: None None

População: None

Key Statistics

3

Estudos

400

Participantes

Positive

B

Nota

Referenced Papers

Beneficial microbes 2019 45 citações
Beneficial microbes 2019 29 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
1-2 billion CFU/day
ibssupport:
2 billion CFU/day (GBI-30 6086 strain)

Limite superior: Well-tolerated up to 6 billion CFU/day in clinical trials

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
None -- Positive --
None 4 weeks Positive 61
None 12 weeks Positive 100
Various probiotic strains/mixtures -- Positive --
20.5% 12 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

Melhor horário: With meals for optimal spore germination and colonization

Safety & Side Effects

Efeitos Colaterais Relatados

  • Mild gas during initial use (generally less than other probiotics due to spore form)
  • Occasional bloating
  • Rare loose stools

Interações Conhecidas

  • Antibiotics (spore form is more resistant than vegetative probiotics, but spacing still recommended)
  • Immunosuppressants (theoretical risk in immunocompromised patients)

Ingestão máxima tolerável: Well-tolerated up to 6 billion CFU/day in clinical trials

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Bacillus coagulans help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Bacillus coagulans may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Bacillus coagulans should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-2 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacillus coagulans?
Reported side effects may include Mild gas during initial use (generally less than other probiotics due to spore form), Occasional bloating, Rare loose stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacillus coagulans and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.